טוען...
How is the Ph-like signature being incorporated into ALL therapy?
Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is a recently identified high risk disease subtype characterized by a gene expression profile similar to that observed in Philadelphia chromosome-positive (Ph-positive) ALL, but without an underlying BCR-ABL1 translocation. Adul...
שמור ב:
| הוצא לאור ב: | Best Pract Res Clin Haematol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6053910/ https://ncbi.nlm.nih.gov/pubmed/29050695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2017.06.001 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|